EUVIMEDOpdag EUVIMED
Video/AudioStudienprotokoll

A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia – Sex Hormone And Urinary Control Effects

Yanlei Wu, Wangjia Ma

Journal of Visualized Experiments · 2026

DOI: 10.3791/70785 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Yanlei Wu and 1 co-authors. Institution: Department of Urology, Haiyan County People's Hospital. Major MEDLINE topics: Finasteride, Prostatic Hyperplasia, Prazosin, Gonadal Steroid Hormones. 42 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

To investigate the clinical effect of terazosin hydrochloride combined with finasteride in benign prostatic hyperplasia (BPH), and to analyze its effect on sex hormones and urinary control. This retrospective propensity score‑matched (PSM) cohort study included BPH patients treated between January 2020 and March 2021. 1:1 PSM using logistic regression with prespecified covariates (age, BMI, IPSS, Qmax, PVR, PV, PSA, CRP, T, E2, DHT, incontinence episodes, ICIQ‑SF); inclusion criteria (age 50‑80 years, IPSS ≥ 8, PSA > 1.4 ng/mL, PV ≥ 40 mL, Qmax ≤ 15 mL/s); exclusion of prior prostate surgery or 5α‑reductase/α1‑blocker use; 12‑month treatment and 36 month follow up with outcomes measured at 6, 12, 24, 36 months. Sixty patients were allocated to each group after PSM. The combination group showed significantly greater improvements in IPSS, Qmax, PVR, and PV (all P 0.05). The terazosin‑- finasteride regimen is associated with improved long-term outcomes, better urinary control, and favorable hormonal changes, though hormonal effects are primarily attributable to finasteride.

Subjects

MeSH terms (MEDLINE)

FinasterideProstatic HyperplasiaPrazosinGonadal Steroid HormonesHumansMaleMiddle AgedAgedPropensity ScoreRetrospective Studies5-alpha Reductase InhibitorsDrug Therapy, Combination

Substances

FinasterideTerazosinPrazosinGonadal Steroid Hormones5-alpha Reductase Inhibitors

Authors and institutions

  • Department of Urology, Haiyan County People's Hospital.
  • Department of Urology, Haiyan County Traditional Chinese Medical Hospital; mwjia1986@hotmail.com.

Cite

APA

Wu, Y., & Ma, W. (2026). A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia – Sex Hormone And Urinary Control Effects. Journal of Visualized Experiments. https://doi.org/10.3791/70785

Vancouver

Wu Y, Ma W. A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia – Sex Hormone And Urinary Control Effects. Journal of Visualized Experiments. 2026. doi:10.3791/70785

BibTeX
@article{Wu2026,
  author = {Wu, Yanlei and Ma, Wangjia},
  title = {A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia – Sex Hormone And Urinary Control Effects},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/70785}
}
Start for free →